Cargando…

Ruxolitinib Controls Lymphoproliferation and Diabetes in a STAT3-GOF Patient

Detalles Bibliográficos
Autores principales: Wegehaupt, Oliver, Muckenhaupt, Tina, Johnson, Matthew B, Schwab, Karl Otfried, Speckmann, Carsten
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7567728/
https://www.ncbi.nlm.nih.gov/pubmed/32944850
http://dx.doi.org/10.1007/s10875-020-00864-w
_version_ 1783596387112321024
author Wegehaupt, Oliver
Muckenhaupt, Tina
Johnson, Matthew B
Schwab, Karl Otfried
Speckmann, Carsten
author_facet Wegehaupt, Oliver
Muckenhaupt, Tina
Johnson, Matthew B
Schwab, Karl Otfried
Speckmann, Carsten
author_sort Wegehaupt, Oliver
collection PubMed
description
format Online
Article
Text
id pubmed-7567728
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-75677282020-10-19 Ruxolitinib Controls Lymphoproliferation and Diabetes in a STAT3-GOF Patient Wegehaupt, Oliver Muckenhaupt, Tina Johnson, Matthew B Schwab, Karl Otfried Speckmann, Carsten J Clin Immunol Letter to Editor Springer US 2020-09-17 2020 /pmc/articles/PMC7567728/ /pubmed/32944850 http://dx.doi.org/10.1007/s10875-020-00864-w Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Letter to Editor
Wegehaupt, Oliver
Muckenhaupt, Tina
Johnson, Matthew B
Schwab, Karl Otfried
Speckmann, Carsten
Ruxolitinib Controls Lymphoproliferation and Diabetes in a STAT3-GOF Patient
title Ruxolitinib Controls Lymphoproliferation and Diabetes in a STAT3-GOF Patient
title_full Ruxolitinib Controls Lymphoproliferation and Diabetes in a STAT3-GOF Patient
title_fullStr Ruxolitinib Controls Lymphoproliferation and Diabetes in a STAT3-GOF Patient
title_full_unstemmed Ruxolitinib Controls Lymphoproliferation and Diabetes in a STAT3-GOF Patient
title_short Ruxolitinib Controls Lymphoproliferation and Diabetes in a STAT3-GOF Patient
title_sort ruxolitinib controls lymphoproliferation and diabetes in a stat3-gof patient
topic Letter to Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7567728/
https://www.ncbi.nlm.nih.gov/pubmed/32944850
http://dx.doi.org/10.1007/s10875-020-00864-w
work_keys_str_mv AT wegehauptoliver ruxolitinibcontrolslymphoproliferationanddiabetesinastat3gofpatient
AT muckenhaupttina ruxolitinibcontrolslymphoproliferationanddiabetesinastat3gofpatient
AT johnsonmatthewb ruxolitinibcontrolslymphoproliferationanddiabetesinastat3gofpatient
AT schwabkarlotfried ruxolitinibcontrolslymphoproliferationanddiabetesinastat3gofpatient
AT speckmanncarsten ruxolitinibcontrolslymphoproliferationanddiabetesinastat3gofpatient